Northwestern Mutual Wealth Management
OCUL icon

Northwestern Mutual Wealth Management’s Ocular Therapeutix OCUL Stock Holding History

Northwestern Mutual Wealth Management’s Portfolio OCUL Stock Details OCUL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-1,000
Closed -$4K – 3430
2022
Q3 		$4K Hold
1,000
– – ﹤0.01% 2747
2022
Q2 		$4K Hold
1,000
– – ﹤0.01% 2782
2022
Q1 		$5K Hold
1,000
– – ﹤0.01% 2747
2021
Q4 		$7K Buy
+1,000
New +$7.77K ﹤0.01% 2685

Other funds holding OCUL

SR
Summer Road West Palm Beach, Florida $142M AUM 43.61% 1-Year Est. Return
OM
Opaleye Management Boston, Massachusetts $759M AUM 124.8% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
DAM
Deltec Asset Management New York $677M AUM 31.67% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
ECM
Endurant Capital Management San Mateo, California $17.4M AUM 7.38% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Northwestern Mutual Wealth Management's OCUL Position: Q4 2022 in Review

Northwestern Mutual Wealth Management sold out of Ocular Therapeutix (OCUL) in Q4 2022, closing a stake of 1,000 shares — an estimated $4K sold.

Northwestern Mutual Wealth Management first reported a position in OCUL in Q4 2021 and held it in 4 quarters. The position peaked at $7K in Q4 2021. 116 funds tracked by Wall St. Rank hold OCUL as of Q4 2022.

  • Northwestern Mutual Wealth Management reported no remaining Ocular Therapeutix position as of Q4 2022 after selling out during the quarter.
  • Northwestern Mutual Wealth Management sold 1,000 Ocular Therapeutix shares in Q4 2022, an estimated $4K.
  • Northwestern Mutual Wealth Management first reported a position in Ocular Therapeutix in Q4 2021 and held it in 4 quarters.
  • Northwestern Mutual Wealth Management's Ocular Therapeutix position peaked at $7K in Q4 2021.
  • 116 funds tracked by Wall St. Rank held Ocular Therapeutix as of Q4 2022.

Based on Northwestern Mutual Wealth Management's 13F filing for Q4 2022, filed 21 Feb 2023.